Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene

Giuseppa Patti, Saverio Scianguetta, Domenico Roberti, Alberto Di Mascio, Antonio Balsamo, Milena Brugnara, Marco Cappa, Maddalena Casale, Paolo Cavarzere, Sarah Cipriani, Sabrina Corbetta, Rossella Gaudino, Lorenzo Iughetti, Lucia Martini, Flavia Napoli, Alessandro Peri, Mariacarolina Salerno, Roberto Salerno, Elena Passeri, Mohamad MaghnieSilverio Perrotta, Natascia Di Iorgi

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Autosomal dominant neurohypophyseal diabetes insipidus (adNDI) is caused by arginine vasopressin (AVP) deficiency resulting from mutations in the AVP-NPII gene encoding the AVP preprohormone.

AIM: To describe the clinical and molecular features of Italian unrelated families with central diabetes insipidus.

PATIENTS AND METHODS: We analyzed AVP-NPII gene in 13 families in whom diabetes insipidus appeared to be segregating.

RESULTS: Twenty-two patients were found to carry a pathogenic AVP-NPII gene mutation. Two novel c.173 G>C (p.Cys58Ser), c.215 C>A (p.Ala72Glu) missense mutations and additional 8 different mutations previously described were identified; nine were missense and 1 non sense mutation. Most mutations (8 out of 10) occurred in the region encoding for the NPII moiety; 2 mutations were detected in exon 1. No mutations were found in exon 3. Median age of onset was 32.5 months with a variability within the same mutation (3 to 360 months). No clear genotype-phenotype correlation has been observed, except for the c.55 G>A (p.Ala19Thr) mutation, which led to a later onset of disease (median age 120 months). Brain magnetic resonance imaging (MRI) revealed absence of posterior pituitary hyperintensity in 8 out of 15 subjects, hypointense signal in 4 and normal signal in 2. Follow-up MRI showed the disappearance of the posterior pituitary hyperintensity after 6 years in one case.

CONCLUSION: adNDI is a progressive disease with a variable age of onset. Molecular diagnosis and counseling should be provided to avoid unnecessary investigations and to ensure an early and adequate treatment.

Original languageEnglish
JournalEuropean Journal of Endocrinology
DOIs
Publication statusE-pub ahead of print - Jun 1 2019

Fingerprint

Neurogenic Diabetes Insipidus
Vasopressins
Arginine Vasopressin
Mutation
Genes
Age of Onset
Exons
Magnetic Resonance Imaging
Diabetes Insipidus
Genetic Association Studies
Missense Mutation
Counseling

Cite this

Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene. / Patti, Giuseppa; Scianguetta, Saverio; Roberti, Domenico; Di Mascio, Alberto; Balsamo, Antonio; Brugnara, Milena; Cappa, Marco; Casale, Maddalena; Cavarzere, Paolo; Cipriani, Sarah; Corbetta, Sabrina; Gaudino, Rossella; Iughetti, Lorenzo; Martini, Lucia; Napoli, Flavia; Peri, Alessandro; Salerno, Mariacarolina; Salerno, Roberto; Passeri, Elena; Maghnie, Mohamad; Perrotta, Silverio; Di Iorgi, Natascia.

In: European Journal of Endocrinology, 01.06.2019.

Research output: Contribution to journalArticle

Patti, G, Scianguetta, S, Roberti, D, Di Mascio, A, Balsamo, A, Brugnara, M, Cappa, M, Casale, M, Cavarzere, P, Cipriani, S, Corbetta, S, Gaudino, R, Iughetti, L, Martini, L, Napoli, F, Peri, A, Salerno, M, Salerno, R, Passeri, E, Maghnie, M, Perrotta, S & Di Iorgi, N 2019, 'Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene', European Journal of Endocrinology. https://doi.org/10.1530/EJE-19-0299
Patti, Giuseppa ; Scianguetta, Saverio ; Roberti, Domenico ; Di Mascio, Alberto ; Balsamo, Antonio ; Brugnara, Milena ; Cappa, Marco ; Casale, Maddalena ; Cavarzere, Paolo ; Cipriani, Sarah ; Corbetta, Sabrina ; Gaudino, Rossella ; Iughetti, Lorenzo ; Martini, Lucia ; Napoli, Flavia ; Peri, Alessandro ; Salerno, Mariacarolina ; Salerno, Roberto ; Passeri, Elena ; Maghnie, Mohamad ; Perrotta, Silverio ; Di Iorgi, Natascia. / Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene. In: European Journal of Endocrinology. 2019.
@article{8a59b3d10b1f4954bb14bfa40cbf5144,
title = "Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene",
abstract = "BACKGROUND: Autosomal dominant neurohypophyseal diabetes insipidus (adNDI) is caused by arginine vasopressin (AVP) deficiency resulting from mutations in the AVP-NPII gene encoding the AVP preprohormone.AIM: To describe the clinical and molecular features of Italian unrelated families with central diabetes insipidus.PATIENTS AND METHODS: We analyzed AVP-NPII gene in 13 families in whom diabetes insipidus appeared to be segregating.RESULTS: Twenty-two patients were found to carry a pathogenic AVP-NPII gene mutation. Two novel c.173 G>C (p.Cys58Ser), c.215 C>A (p.Ala72Glu) missense mutations and additional 8 different mutations previously described were identified; nine were missense and 1 non sense mutation. Most mutations (8 out of 10) occurred in the region encoding for the NPII moiety; 2 mutations were detected in exon 1. No mutations were found in exon 3. Median age of onset was 32.5 months with a variability within the same mutation (3 to 360 months). No clear genotype-phenotype correlation has been observed, except for the c.55 G>A (p.Ala19Thr) mutation, which led to a later onset of disease (median age 120 months). Brain magnetic resonance imaging (MRI) revealed absence of posterior pituitary hyperintensity in 8 out of 15 subjects, hypointense signal in 4 and normal signal in 2. Follow-up MRI showed the disappearance of the posterior pituitary hyperintensity after 6 years in one case.CONCLUSION: adNDI is a progressive disease with a variable age of onset. Molecular diagnosis and counseling should be provided to avoid unnecessary investigations and to ensure an early and adequate treatment.",
author = "Giuseppa Patti and Saverio Scianguetta and Domenico Roberti and {Di Mascio}, Alberto and Antonio Balsamo and Milena Brugnara and Marco Cappa and Maddalena Casale and Paolo Cavarzere and Sarah Cipriani and Sabrina Corbetta and Rossella Gaudino and Lorenzo Iughetti and Lucia Martini and Flavia Napoli and Alessandro Peri and Mariacarolina Salerno and Roberto Salerno and Elena Passeri and Mohamad Maghnie and Silverio Perrotta and {Di Iorgi}, Natascia",
year = "2019",
month = "6",
day = "1",
doi = "10.1530/EJE-19-0299",
language = "English",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",

}

TY - JOUR

T1 - Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene

AU - Patti, Giuseppa

AU - Scianguetta, Saverio

AU - Roberti, Domenico

AU - Di Mascio, Alberto

AU - Balsamo, Antonio

AU - Brugnara, Milena

AU - Cappa, Marco

AU - Casale, Maddalena

AU - Cavarzere, Paolo

AU - Cipriani, Sarah

AU - Corbetta, Sabrina

AU - Gaudino, Rossella

AU - Iughetti, Lorenzo

AU - Martini, Lucia

AU - Napoli, Flavia

AU - Peri, Alessandro

AU - Salerno, Mariacarolina

AU - Salerno, Roberto

AU - Passeri, Elena

AU - Maghnie, Mohamad

AU - Perrotta, Silverio

AU - Di Iorgi, Natascia

PY - 2019/6/1

Y1 - 2019/6/1

N2 - BACKGROUND: Autosomal dominant neurohypophyseal diabetes insipidus (adNDI) is caused by arginine vasopressin (AVP) deficiency resulting from mutations in the AVP-NPII gene encoding the AVP preprohormone.AIM: To describe the clinical and molecular features of Italian unrelated families with central diabetes insipidus.PATIENTS AND METHODS: We analyzed AVP-NPII gene in 13 families in whom diabetes insipidus appeared to be segregating.RESULTS: Twenty-two patients were found to carry a pathogenic AVP-NPII gene mutation. Two novel c.173 G>C (p.Cys58Ser), c.215 C>A (p.Ala72Glu) missense mutations and additional 8 different mutations previously described were identified; nine were missense and 1 non sense mutation. Most mutations (8 out of 10) occurred in the region encoding for the NPII moiety; 2 mutations were detected in exon 1. No mutations were found in exon 3. Median age of onset was 32.5 months with a variability within the same mutation (3 to 360 months). No clear genotype-phenotype correlation has been observed, except for the c.55 G>A (p.Ala19Thr) mutation, which led to a later onset of disease (median age 120 months). Brain magnetic resonance imaging (MRI) revealed absence of posterior pituitary hyperintensity in 8 out of 15 subjects, hypointense signal in 4 and normal signal in 2. Follow-up MRI showed the disappearance of the posterior pituitary hyperintensity after 6 years in one case.CONCLUSION: adNDI is a progressive disease with a variable age of onset. Molecular diagnosis and counseling should be provided to avoid unnecessary investigations and to ensure an early and adequate treatment.

AB - BACKGROUND: Autosomal dominant neurohypophyseal diabetes insipidus (adNDI) is caused by arginine vasopressin (AVP) deficiency resulting from mutations in the AVP-NPII gene encoding the AVP preprohormone.AIM: To describe the clinical and molecular features of Italian unrelated families with central diabetes insipidus.PATIENTS AND METHODS: We analyzed AVP-NPII gene in 13 families in whom diabetes insipidus appeared to be segregating.RESULTS: Twenty-two patients were found to carry a pathogenic AVP-NPII gene mutation. Two novel c.173 G>C (p.Cys58Ser), c.215 C>A (p.Ala72Glu) missense mutations and additional 8 different mutations previously described were identified; nine were missense and 1 non sense mutation. Most mutations (8 out of 10) occurred in the region encoding for the NPII moiety; 2 mutations were detected in exon 1. No mutations were found in exon 3. Median age of onset was 32.5 months with a variability within the same mutation (3 to 360 months). No clear genotype-phenotype correlation has been observed, except for the c.55 G>A (p.Ala19Thr) mutation, which led to a later onset of disease (median age 120 months). Brain magnetic resonance imaging (MRI) revealed absence of posterior pituitary hyperintensity in 8 out of 15 subjects, hypointense signal in 4 and normal signal in 2. Follow-up MRI showed the disappearance of the posterior pituitary hyperintensity after 6 years in one case.CONCLUSION: adNDI is a progressive disease with a variable age of onset. Molecular diagnosis and counseling should be provided to avoid unnecessary investigations and to ensure an early and adequate treatment.

U2 - 10.1530/EJE-19-0299

DO - 10.1530/EJE-19-0299

M3 - Article

C2 - 31238300

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

ER -